Integrated wound-care platform
Marrian Medical Technologies is building an integrated wound-care platform — a therapy system designed to accelerate healing, and an intelligence layer that measures whether it's working.
Two products. One company. Only Marrian owns both halves — the therapy that treats the wound and the software that quantifies its response. That's the dataset no image-only competitor can build.
Studio-supported · Inventor-connected · Efficacy under preclinical investigation
Mission
Marrian Technologies was formed around a clear objective: to help move promising wound-care technology from research toward practical future application.
The company is developing the partnerships, technical pathway, operational infrastructure, regulatory strategy, and funding foundation needed to advance the technology responsibly.
This work is guided by compassion, ethical leadership, evidence-based innovation, environmental stewardship, and patient safety.
Research Foundation
Technology Development
Validation Planning
Future goalCommercialization Readiness
Future goalFuture Patient Impact
Future goalThe Need
Wound management remains a complex challenge for patients, caregivers, clinicians, healthcare systems, and military medical environments.
The company is exploring how two relevant wound-care modalities may be brought together within a coordinated system.
The company is building the partnerships, evidence strategy, regulatory planning, and commercial foundation required for responsible advancement.
The Platform
A therapy system designed to accelerate wound closure, and an intelligence layer that measures whether it's working. Neither product is subordinated to the other — they are engineered to inform each other.
An integrated wound-care therapy device advanced in partnership with the University of Hawaii and the original inventors, on a Department of War transition pathway. Designed to accelerate wound closure; efficacy under preclinical investigation.
Therapy detailsEdge-deployed computer vision and predictive software that translates wound imaging, adherence, and therapy telemetry into a structured signal of whether healing is on track.
Intelligence detailsWhy both. Every AI wound-care company analyzes images. None own a therapy device. Owning both halves is the only way to fuse imaging with actual therapy data — pressure levels, seal failures, stim dose, adherence — against healing outcomes.
Read the full thesisDevelopment Priorities
Supporting continued refinement and evaluation of the integrated wound-care concept.
Helping define the technical, preclinical, clinical, and usability evidence that may be required.
Establishing a responsible framework for future regulatory, quality-system, and compliance activities.
Developing the company structure, market pathway, partnerships, and operational plans required to support future commercialization.
Building relationships with investors, grant organizations, research institutions, government stakeholders, advisors, and industry partners.
Principles
Compassion
Patients, caregivers, and clinicians stay central.
Ethical Leadership
Integrity across science, partnerships, and funding.
Innovation
Evidence-based opportunities in healing technologies.
Environmental Stewardship
Considering long-term materials and lifecycle impact.
Safety
Patient well-being remains foundational.
Team
Co-founder and Chief Executive Officer
Co-founder and Chief Operating Officer
Board of Directors
Collaborative Ecosystem
Marrian Technologies is being developed within an emerging network of inventors, academic relationships, clinical connections, a startup studio program, federal innovation networks, and commercialization-support organizations.
The nature and scope of each relationship may differ. References to organizations should not be interpreted as investment, endorsement, sponsorship, procurement, regulatory approval, or formal institutional partnership unless expressly confirmed.
Marrian Technologies welcomes conversations with investors, research institutions, clinical collaborators, government stakeholders, technology-transfer professionals, advisors, grant organizations, and medical-device partners who share its commitment to responsible medical innovation.
